telix partners with subtle medical to enhance pet imaging with ai technology

Telix Pharmaceuticals has partnered with Subtle Medical to integrate AI-powered technology into its PET imaging processes.

Collaboration with Subtle Medical

The collaboration focuses on using Subtle Medical's SubtlePET™ software, which has FDA clearance and can reduce PET scan times by up to 75% without compromising image quality.

This integration is expected to enhance patient experiences by minimizing wait times and reducing the duration patients must remain motionless during scans.

Benefits of the Partnership

The integration of AI technology into Telix's imaging processes allows medical facilities to optimize workflows and resource utilization.

It also aligns with trends in the healthcare sector that prioritize patient-centric solutions and operational efficiency.

Target Market and Expansion Plans

The initial target market for this partnership is the U.S., with plans to expand to other regions pending regulatory approvals.

Importance of Technological Innovation

This partnership underscores the growing importance of technological innovation in the biopharmaceutical industry, particularly in oncology and rare diseases.

Telix Pharmaceuticals is committed to expanding its portfolio of products, and the integration of AI into its imaging solutions is expected to play a crucial role in its strategic vision.

Trending
Subcategory:
Countries:
Companies:
Currencies:
People:

Machinary offers a groundbreaking, modular, and customizable solution that provides advanced financial news and statistical analysis. Our platform goes beyond traditional quantitative analysis, offering users a comprehensive understanding of real-time market dynamics, event detection, and risk analysis.

Address

Waitlist

We’re granting exclusive early access to the first 500 users from december 20.

© 2024 by Machinary.com - Version: 1.0.0.0. All rights reserved

Layout

Color mode

Theme mode

Layout settings